Skip to Main Content

MSC

Animal-origin-free proteins for every step of MSC manufacturing.

From tissue procurement to cryopreservation, recombinant albumin, transferrin and insulin-transferrin supplements lower variability and keep serum and plasma-derived material out of the MSC product.

Where InVitria proteins fit in MSC Manufacturing

MSC manufacturing depends on proteins that carry, feed and protect adherent cells from donor tissue through expansion, harvest, formulation and freezing. Fetal bovine serum, human platelet lysate, bovine serum albumin and plasma-derived human serum albumin supply those proteins with lot-to-lot variability and animal- or human-origin risk. Defined, animal-origin-free recombinant albumin, transferrin and insulin-transferrin supplements supply the same functions, step by step, into the final drug product.

Where our products fit

The MSC workflow, step by step.

Select a step to see where InVitria products fit.

Tissue Procurement

Procure source tissue, such as bone marrow, adipose, or umbilical cord, and protect the cells during transport with defined, animal-origin-free components.

Overview

Tissue procurement is the first step in MSC manufacturing. MSCs are isolated from a source tissue, most commonly bone marrow, adipose tissue, or umbilical cord, and the same cell type can be drawn from several tissues. MSC therapy is usually allogeneic, so the tissue typically comes from a healthy donor and supports an off-the-shelf product.

Source tissue is collected as a bone marrow aspirate, a lipoaspirate, or a tissue sample, then transported to the manufacturing site. Time, temperature, and handling between collection and isolation can affect cell recovery and the quality of the population that establishes in culture.

Protecting the cells during this early window supports recovery and a consistent starting point. A defined, animal-origin-free stabilizing protein avoids introducing serum- or animal-derived material at the start of the process.

Functions

Starting Material Stabilization

MSCs are isolated from donor tissue, and the interval between collection and isolation exposes cells to temperature shifts, handling, and surface contact. Recovery and the quality of the population that establishes in culture depend in part on how well cells are protected during transport and hold. A stabilizing protein supports cell health through this early window, before isolation begins.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Serum- or plasma-derived albumin used to stabilize collected tissue and cells.

MSC Isolation

Recover MSCs from the source tissue by density separation or enzymatic digestion and plastic adherence, with defined, animal-origin-free albumin supporting the cells through isolation.

Overview

Cell isolation recovers MSCs from the source tissue and establishes the primary culture. For bone marrow, the mononuclear cell fraction is separated by density-gradient centrifugation. For adipose and cord tissue, the tissue is enzymatically digested, often with collagenase, to release cells. MSCs are then selected by their ability to adhere to tissue-culture surfaces, while non-adherent cells are washed away.

Isolation and the first days of culture expose cells to enzymatic treatment, washing, and surface contact. Traditional protocols use serum to support attachment and early growth; defined, serum-free isolation is increasingly used to reduce variability and animal-origin risk.

A defined, animal-origin-free recombinant albumin supports cell attachment and protects cells through enzymatic treatment and washing, while keeping isolation free of serum-derived material.

Functions

Cell Protection & Stabilization

During isolation, cells are exposed to density separation or enzymatic digestion, repeated washing, and the stress of establishing in culture. Albumin supports attachment and viability by transporting fatty acids and binding reactive species, buffering cells against handling and oxidative stress as the primary culture establishes.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Serum or bovine serum albumin (BSA) used in isolation and early culture media.

MSC Expansion

Expand MSCs through adherent passaging while maintaining viability, identity, and potency, reducing undefined and animal-origin components in expansion media.

Overview

Cell expansion grows MSCs to the therapeutic dose. MSCs are anchorage-dependent, so they are expanded as adherent cultures, in flasks, multi-layer vessels, or on microcarriers in stirred-tank bioreactors, through serial passaging. Cells must proliferate while maintaining viability, identity, and differentiation potential.

Expansion media traditionally rely on fetal bovine serum or human platelet lysate, which introduce lot-to-lot variability and animal- or human-origin risk. Defined media replace these with recombinant carrier protein, iron, and metabolic components, alongside the growth factors MSCs require. Outcomes depend on media composition, surface, passage number, and shear in bioreactors.

A defined, animal-origin-free expansion strategy supports consistent growth, preserves MSC identity and potency, and reduces the variability that serum and platelet lysate introduce across runs.

Functions

Iron Transport

Proliferating MSCs require iron for metabolism and DNA synthesis during expansion. In serum-free and defined media, transferrin delivers iron in a controlled, protein-bound form through the transferrin receptor, supporting proliferation while limiting the oxidative stress associated with free iron. Transferrin is a core component of defined MSC media.

Recommendation
Optiferrin®

Recombinant human transferrin, lyophilized, for iron delivery in serum-free and chemically defined media.

Commonly replaces
Serum- or plasma-derived transferrin, and serum as an iron source.

Growth Factor Signaling

Serum-free and platelet-lysate-free MSC expansion media replace the mitogens those supplements supplied with a defined growth-factor set, and EGF is a standard member of it alongside FGF2 and PDGF. EGF stimulates MSC proliferation through EGFR and ERK signaling while preserving the multipotency and immunomodulatory phenotype the product depends on, which matters as cells are carried through multiple passages toward the therapeutic dose. A defined, animal-origin-free EGF in a ready-to-use liquid gives consistent mitogenic input across passages and lots, with minimal endotoxin and host-cell protein in a product that is usually not purified downstream.

Recommendation
OptiKine™ EGF

Recombinant human Epidermal Growth Factor from an animal-origin-free expression system, for epithelial, keratinocyte, and organoid culture and stem-cell proliferation.

Commonly replaces
Growth factors supplied by fetal bovine serum or human platelet lysate, and E. coli- or mammalian-cell-derived recombinant human EGF in serum-free MSC media.

Carrier & Protection

Albumin is the primary protein carrier in defined culture. It binds and transports fatty acids, lipids, and metal ions, contributes antioxidant capacity, and buffers cells against handling and, in bioreactors, shear stress. During MSC expansion this carrier and protective role supports viability and consistent growth, particularly in microcarrier and stirred-tank systems where shear is a concern.

Recommendation
Cellastim® S

Cell culture recombinant albumin to enhance proliferation in serum free and chemically defined cell culture. Lyophilized.

Commonly replaces
Serum albumin (HSA/BSA) in expansion media.

Serum Reduction / Replacement

MSC expansion has traditionally depended on fetal bovine serum or human platelet lysate to supply carrier proteins, iron, and metabolic components. These introduce lot-to-lot variability and animal- or human-origin risk. Defined blends replace those functions with recombinant and chemically defined components in a single addition, supporting serum reduction or replacement while keeping the formulation animal-origin-free and consistent across runs.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
Fetal bovine serum (FBS) and human platelet lysate (hPL) in MSC expansion media.

Optional Differentiation & Potency Characterization

Most clinical MSC products are delivered undifferentiated (immunomodulatory / paracrine mechanism). This step applies as a production operation only to lineage-committed products; tri-lineage differentiation otherwise serves as an ISCT identity/potency assay on a QC sample.

Overview

The defining mechanism of most MSC therapies is paracrine and immunomodulatory, so the drug product is typically the undifferentiated MSC. Directed differentiation is a production step only for lineage-committed products — e.g., osteoblasts or chondrocytes for bone/cartilage grafts.

Tri-lineage differentiation (osteogenic, chondrogenic, adipogenic) is also the ISCT minimal-criteria identity assay, run on a characterization sample rather than the full batch. Where osteogenic commitment is intended, holo-lactoferrin supports osteogenic differentiation.

Functions

Osteogenic Differentiation Support

Osteogenic commitment directs MSCs toward bone-forming cells, induced with factors such as dexamethasone, ascorbate, and beta-glycerophosphate. Lactoferrin has been shown to support MSC osteogenic differentiation and proliferation, signaling through TGF-beta and PI3K/AKT pathways, making it relevant to bone-repair and bone tissue-engineering products.

Recommendation
Lacromin®

Recombinant human holo-lactoferrin, an iron-saturated lyophilized powder for serum-free and chemically defined cell culture media.

Commonly replaces
Bovine lactoferrin used in research-grade osteogenic media.

Chondrogenic Differentiation Support

Chondrogenic commitment directs MSCs toward cartilage cells, induced with TGF-beta3 in 3D pellet or scaffold culture. Chondrogenic media are built on a defined base of insulin, transferrin, and selenium, which support cell metabolism and viability during the differentiation window. The inducing growth factor is supplied separately.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
Serum and ITS premix with BSA in chondrogenic media.

Adipogenic Differentiation Support

Adipogenic commitment directs MSCs toward fat cells, induced with insulin together with IBMX, dexamethasone, and indomethacin. Insulin is both an inducing and a base component of adipogenic media, and a defined carrier and iron supply support the cells through differentiation. The small-molecule inducers are supplied separately.

Recommendation
ITS Animal-Free™

Chemically defined 100x recombinant insulin, recombinant human transferrin, and selenium concentrate for serum-free and reduced-serum mammalian cell culture.

Commonly replaces
Serum and insulin from undefined sources in adipogenic media.

Harvest & Detachment

Detach adherent MSCs and concentrate them for formulation, with defined, animal-origin-free albumin protecting cells through enzymatic harvest and washing.

Overview

Harvest releases the expanded or differentiated MSCs from their growth surface and concentrates them for formulation. Because MSCs are anchorage-dependent, they must be enzymatically detached, typically with recombinant trypsin or TrypLE, from flasks, multi-layer vessels, or microcarriers. The detached cells are washed to remove the enzyme and spent media, then concentrated by centrifugation or filtration.

Enzymatic detachment and washing expose cells to mechanical and proteolytic stress, and harsh or prolonged enzyme exposure can affect MSC surface markers and function. Wash and concentration buffers commonly contain albumin to protect cells and quench residual enzyme activity during this step.

A defined, animal-origin-free recombinant albumin protects cells through detachment and washing while avoiding the animal-derived residuals that would otherwise carry toward the final product.

Functions

Cell Protection & Stabilization

During harvest, MSCs are enzymatically detached from their growth surface and washed, which exposes them to proteolytic and mechanical stress. Harsh enzyme exposure can alter MSC surface markers and function. Albumin protects cells through detachment, helps neutralize residual enzyme activity, and buffers cells against shear during washing and concentration.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Serum or bovine serum albumin (BSA) used to quench enzyme and protect cells at harvest.

Final Formulation & Fill Prep

Formulate the MSCs into their final matrix with defined, animal-origin-free recombinant albumin, a drug-product excipient that stabilizes the product for fill and storage.

Overview

Final formulation and fill prep brings the MSC product to its finished form. The concentrated cells are suspended in the matrix they will be stored and administered in, then filled into the primary container, a cryobag or vial. A common formulation is an electrolyte solution such as Plasma-Lyte A with a cryoprotectant and albumin.

Albumin is a standard excipient in these matrices. It stabilizes the cells and protects them through formulation and into freezing. Because this is the drug product, excipient safety matters: plasma-derived albumin carries adventitious-agent risk that a recombinant source removes.

A defined, animal-origin-free recombinant albumin stabilizes the formulated product while keeping the final matrix free of human- and animal-derived material as it goes to fill.

Functions

Formulation Stabilization

In final formulation, the concentrated cells are suspended in the matrix they will be stored and administered in, commonly an electrolyte solution with a cryoprotectant. Albumin is a standard excipient in this matrix. It stabilizes cells, buffers them against the osmotic and handling stress of formulation and the hold before freezing, and limits adsorption to the container. As a drug-product excipient, its quality and safety profile carry into the final product.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived human serum albumin (HSA) used as a formulation excipient.

Cryopreservation

Freeze and store the MSC product, with defined, animal-origin-free albumin supporting cell stability through freeze-thaw and recovery.

Overview

Cryopreservation freezes and stores the finished product. The formulated cells are cooled in a controlled-rate freezer and held in cryogenic storage, typically below -120°C in the vapor phase of liquid nitrogen, then thawed at the point of care before infusion. Freezing enables off-the-shelf supply, shipment, and storage of doses.

Freeze-thaw exposes cells to ice formation and osmotic stress, and post-thaw viability is a known concern for MSC products. Cryopreservation matrices pair a penetrating cryoprotectant such as DMSO with a protein stabilizer. Recombinant albumin has been shown to support MSC stability with DMSO, buffering cell membranes through freezing and supporting viability on thaw.

A defined, animal-origin-free recombinant albumin supports cryostability while keeping the frozen drug product free of human- and animal-derived material.

Functions

Freeze-Thaw Stabilization

Cryopreservation exposes cells to ice crystal formation, osmotic shifts, and membrane stress during freezing and thawing, and post-thaw recovery is a known challenge for MSC products. Cryopreservation matrices pair a penetrating cryoprotectant such as DMSO with a protein stabilizer. Albumin acts as that stabilizer, a non-penetrating component that buffers membranes against osmotic and oxidative stress and supports viability and recovery after thaw.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived human serum albumin (HSA) used as a cryopreservation stabilizer.